California Cannabis Corporate Law Attorney

California’s cannabis and hemp businesses operate inside a corporate legal framework that differs fundamentally from conventional business law. Because adult-use/recreational cannabis remains a Schedule I controlled substance under federal law — and because even state-licensed medical cannabis, now rescheduled to Schedule III, still faces significant federal regulatory constraints — every corporate decision for a cannabis business carries consequences that do not arise in non-cannabis industries. The corporate law practice at the Law Office of Shay Aaron Gilmore is built to produce structurally sound, investor-ready, regulator-defensible companies that can withstand ownership disputes, regulatory scrutiny, and the pressures of a market that changes faster than the law it operates under.

Recognized By

What Corporate Law Covers for Cannabis Businesses

Corporate law governs how a cannabis or hemp business is formed, owned, governed, and transferred. The choice of entity — LLC, corporation, or limited partnership — determines tax treatment, owner liability protection, and the mechanics of how equity is issued. In the cannabis industry, those choices carry additional weight: the California Department of Cannabis Control requires that every owner, financial interest holder, and controller be disclosed and approved on the licensing application, which means the structure of the entity directly determines who can hold or transfer the license.

Capital access compounds the structural decisions. Most institutional lenders will not extend traditional financing to plant-touching cannabis businesses, which makes equity structures and private investment the primary growth engine. A well-drafted operating agreement or shareholder agreement is therefore not just a governance document — it is the foundational contract that controls what happens when investors enter, exit, dispute, or trigger a buyout, and what happens when the company seeks to merge with or acquire another operator.

Governance frameworks must also be calibrated to the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) and DCC regulations that impose ongoing obligations on officers and directors which do not exist in conventional corporate settings. Officers and directors must be disclosed, background-checked, and approved; governance changes must be reported to the DCC within defined timeframes; and certain transfers of ownership or control require advance regulatory approval. Failure to comply can result in license suspension, revocation, or denial of renewal.

LLC Fiduciary Duties in California Cannabis Companies California Corporations Code § 17704.09 governs the fiduciary duties of managers and members in California limited liability companies. Under § 17704.09, managers of a manager-managed LLC owe duties of loyalty and care to the company and its members; in a member-managed LLC, each member managing the business owes those same duties. Cannabis LLCs face a heightened practical risk: the DCC requires disclosure and approval of all persons exercising management authority, meaning that fiduciary duty claims among co-owners can quickly become regulatory events as well as litigation events.

Operating agreements for California cannabis LLCs must be carefully drafted to define, and where permitted by statute, to limit or modify the default fiduciary duties under § 17704.09 — including restricting self-dealing, defining permitted competition, and establishing clear conflict-of-interest procedures. The firm drafts operating agreements that account for both the corporate governance requirements of § 17704.09 and the DCC’s ongoing disclosure and suitability obligations.

Key Corporate Legal Issues in the Cannabis Industry

Federal bankruptcy protection is largely unavailable to plant-touching cannabis businesses. Courts have consistently refused to allow cannabis operators to reorganize under Chapters 7 or 11, on the ground that they involve ongoing violations of federal law. This means the tools available to conventional companies in distress — automatic stays, reorganization, and discharge of debt — are out of reach. Cannabis corporate counsel must therefore build alternative distress provisions into operating agreements: contractual wind-down mechanisms, waterfall provisions, and member buy-out rights that would otherwise be handled by a bankruptcy court.

Note (May 2026): Federal courts have recently recognized Chapter 15 foreign insolvency proceedings for cannabis companies with qualifying international parent structures (see In re The Cannabist Company Holdings, D. Del. 2026). While Chapter 7 and 11 remain unavailable, Chapter 15 may offer a viable restructuring pathway for operators with Canadian or other qualifying foreign structures.

Mergers and acquisitions in this sector require a specialized due diligence approach. Cannabis M&A counsel must assess not just the target’s financial performance but its regulatory compliance history, the transferability of its licenses under California law, the status of its real estate and leases, its tax position under Internal Revenue Code Section 280E, and any outstanding enforcement matters. IRC § 280E — Status as of May/June 2026: Section 280E of the Internal Revenue Code historically prohibited cannabis businesses from deducting ordinary business expenses, because § 280E applies only to businesses trafficking in Schedule I or II controlled substances. On April 22, 2026, the DOJ issued a final order moving state-licensed medical marijuana to Schedule III, removing qualifying state-licensed medical cannabis businesses from § 280E’s scope. The IRS has confirmed that qualifying businesses may deduct ordinary and necessary business expenses under IRC § 162 for the full 2026 tax year. Important Bifurcation: Adult-use/recreational cannabis remains Schedule I and remains subject to § 280E until broader rescheduling is completed. Dual-license operators (medical and recreational) will need to apportion expenses between Schedule III and Schedule I activities; IRS guidance on apportionment is pending. Entity and tax structure decisions must account for this bifurcation, which continues to push effective federal tax rates for adult-use operators toward 70%. For qualifying medical cannabis operators relieved of § 280E as of April 28, 2026, this dynamic no longer applies — creating meaningfully different valuation models for medical versus adult-use entities. Those different valuation models must be factored into every transaction.

Contract enforceability is a live risk. Courts in multiple jurisdictions have declined to enforce cannabis-related contracts on the ground that they require performance of a federally illegal activity. Arbitration clauses, California choice-of-law provisions, and severability language are not boilerplate in this industry — they are the difference between an enforceable agreement and an unenforceable one. The firm drafts corporate documents with those enforcement risks built in from the start.

How Shay Aaron Gilmore Helps

Since opening in 2018, the firm has closed millions of dollars in M&A transactional value for cannabis industry clients — guiding operators and investors through entity formation, capitalization, governance, and complex acquisitions at every stage of the cannabis supply chain. The corporate practice is grounded in legal realism: documents should be drafted not for ideal conditions, but for the conditions cannabis businesses actually operate under — disputes, regulatory shifts, and market volatility

Corporate law services include:

Business entity formation and entity selection
Operating agreements and shareholder agreements
Corporate governance and board advisory
Equity structuring, capitalization tables, and option pools
M&A due diligence and transaction documentation
Ownership and control compliance with DCC licensing rules
Restructuring and wind-down planning
Founder, co-founder, and partnership dispute resolution

What Our Clients Say

Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. Results depend on the specific facts and legal circumstances of each case.

Frequently Asked Questions

Q1. What entity should a California cannabis operator use?

There is no single answer — the right entity depends on capital structure, number of owners, tax posture, and the specific license type. LLCs are common for single-license operators because of pass-through taxation and flexibility, but C-corporations are often preferred where institutional investment is anticipated. The firm walks through that analysis at formation, not after the fact.

Q2. Can I add a new investor without notifying the DCC?

Generally, no. Anyone meeting the DCC’s “owner” or “financial interest holder” definitions must be disclosed, and certain ownership changes require pre-approval. Adding capital is a regulatory event, not just a corporate one — sequencing matters.

Q3. How are buyouts handled if a member wants to exit?

Through buy-sell provisions built into the operating agreement at formation. Without those provisions, a member exit can stall the company for months and trigger valuation disputes. Drafting them early — and pricing them realistically — is the most cost-effective protection available.

Q4. Can a cannabis business file bankruptcy?

Plant-touching cannabis operators have generally been denied access to federal bankruptcy protection. The firm builds contractual analogues — wind-down provisions, waterfall distributions, and assignment-for-benefit-of-creditors mechanisms — directly into the governing documents. Note (May 2026): Chapter 15 has recently emerged as a viable pathway for cannabis companies restructuring through a qualifying foreign parent entity. See the discussion in the “Distressed Deals, Receiverships, and Alternatives to Bankruptcy” section below.

Q5. What is Section 280E and why does it matter at the corporate level?

Section 280E of the Internal Revenue Code prohibits cannabis businesses from deducting ordinary operating expenses for federal income tax purposes. For adult-use/recreational operators, effective federal tax rates run far higher than in non-cannabis industries — a consequence that materially affects valuation, capitalization, and distributions, and that requires corporate documents to be drafted with § 280E exposure modeled in. As of April 22, 2026, qualifying state-licensed medical cannabis businesses are no longer subject to § 280E and may deduct ordinary business expenses under IRC § 162 — corporate documents for medical operators and dual-license operators must account for this bifurcation.

Q6. Does the firm handle multi-state corporate structures?

Yes — for the California-licensed portion of the structure and the holding company architecture above it. Out-of-state licensed subsidiaries are coordinated with local counsel in each jurisdiction.

The April 22 Rescheduling Order: What We Know, What We Don’t, and What to Watch Before June 29

Shay Aaron Gilmore May 25, 2026

The April 22, 2026 rescheduling order moves state-licensed medical marijuana to Schedule III — but leaves adult-use cannabis in Schedule I, creates contested treaty-compliance mechanisms, and opens a June 27 DEA registration deadline that demands immediate attention from California dual A/M operators. Here is what we know, what remains genuinely uncertain, and what to watch before June 29.

Recent and Expected California Cannabis & Hemp Rulemaking to Govern the Licensed Supply Chains for Years to Come

Shay Aaron Gilmore May 13, 2026

California cannabis and hemp operators face five active or anticipated rulemakings in 2026 — covering multipack cannabis goods, pesticide residue testing, cultivation requirements, METRC track-and-trace reform, and AB 8 implementation. California cannabis attorney Shay Aaron Gilmore breaks down each DCC rulemaking proceeding, the AB 8 two-year countdown to hemp-DCC licensing integration, and why administrative law counsel delivers its highest value before any enforcement action begins.

California’s 2026 Cannabis Bills: All Active, All in the Assembly, and a Critical Deadline Approaching

Shay Aaron Gilmore May 4, 2026

Every active 2026 California cannabis bill affecting licensed dispensaries and retailers — including AB 2532’s beverage overhaul — is now sitting in the Assembly Appropriations Committee with a hard May 15 deadline. California cannabis attorney Shay Aaron Gilmore breaks down all of the bills, their current status, who’s sponsoring them, and what operators need to do before the window closes. Read the full legislative update at shaygilmorelaw.com.

Recognized Corporate Law Expertise

Cannabis and hemp businesses in California operate in one of the most volatile regulatory and commercial environments in the country. From formation and capitalization to restructurings, buyouts, and exits, careful corporate planning is essential to preserve value and keep state and local regulators onside. The firm structures entities, boards, and ownership in ways that satisfy the Department of Cannabis Control’s ownership and financial interest rules while still meeting business and tax objectives.

Corporate mandates often require navigating distressed counterparties and incomplete prior work. Recent matters have included stepping into deals midstream after other counsel were unable to close, redesigning transaction structures to obtain regulatory approval, and coordinating with receivers, lenders, and other stakeholders in high‑profile restructurings of publicly traded cannabis groups. The practice also regularly leads controlled takeovers and reorganizations in situations where bankruptcy protections are unavailable because of federal prohibition.

The firm’s corporate work spans new company formation, shareholder and operating agreements, recapitalizations, redemptions and buy‑outs, and governance advice for closely held and investor‑backed operators. It frequently coordinates with litigation, tax, and insolvency co‑counsel where necessary, while remaining lead regulatory and corporate adviser for California license and ownership issues across the capital structure.

Can You Help Me Sell or Buy a Cannabis Business?

From Shay’s interview for the Master’s series on ReelLawyers.com

View Transcript

Absolutely, I can help you purchase or sell a cannabis business in California. I can guide you through the regulatory landscape, including both the state regulatory environment and the local regulations that apply to the business.

If you’re looking to purchase a cannabis business, I can assist in identifying a suitable opportunity for acquisition. And if you’re looking to sell, I can help determine the value of your business by working with you to conduct an evaluation—taking into account intangible assets—and help you develop a marketing strategy for the sale.

Business structure directly impacts legal liability for owners if the company becomes involved in any disputes with third parties, or if there are ownership disputes. Our corporate law practice includes all the services a cannabis or hemp business needs, including but not limited to restructuring business forms, ensuring that your business is adequately capitalized, protecting officers and directors, and advising about ongoing corporate governance. The Law Office of Shay Aaron Gilmore provides legal services for cannabis and hemp operators and investors related to:

Distressed Deals, Receiverships, and Alternatives to Bankruptcy for Cannabis and Hemp Businesses

One of the sharpest corporate‑law distinctions between cannabis and industrial hemp is what happens when a business becomes distressed. In the vast majority of cases, adult-use cannabis businesses cannot access federal bankruptcy protection because adult-use cannabis remains a Schedule I controlled substance, and federal courts have overwhelmingly dismissed Chapter 11 filings by cannabis operators on the ground that the bankruptcy system cannot be used to administer assets tied to ongoing federal crimes. State-licensed medical cannabis businesses, now rescheduled to Schedule III as of April 22, 2026, may present a different analysis — though no court has yet ruled on Chapter 11 eligibility for Schedule III cannabis operators, and caution is warranted. That bar extends beyond plant‑touching companies — courts have also dismissed cases involving cannabis landlords and ancillary service providers. Industrial hemp businesses, by contrast, were removed from the Controlled Substances Act by the 2018 Farm Bill, and federal bankruptcy courts have accepted hemp‑company filings, most notably the GenCanna Global Chapter 11 liquidation in the Eastern District of Kentucky, which confirmed that compliant hemp and CBD companies can reorganize or liquidate under federal bankruptcy law. However, hemp companies whose products raise questions under the Federal Food, Drug, and Cosmetic Act or whose operations straddle the cannabis–hemp line may still face challenges at the courthouse door.

For California cannabis operators locked out of bankruptcy, the primary restructuring tools are state court receiverships, assignments for the benefit of creditors, and negotiated out‑of‑court workouts. Under California Code of Regulations, title 4, section 15024, a court‑appointed receiver can, with timely DCC notification, step into the shoes of a failing cannabis licensee and continue operating the business while a buyer applies for new state licenses at the same location — a critical bridge that keeps the site, the workforce, and the license pipeline alive during a transition. Assignments for the benefit of creditors offer a more private, contractual alternative, allowing a distressed company to transfer assets to an assignee who liquidates them and distributes proceeds without ongoing court supervision. Because hemp businesses have federal bankruptcy available as an option, the receivership and ABC tools are less commonly needed on the hemp side — but they can still be relevant where a hemp operator also holds cannabis licenses or where speed and confidentiality outweigh the advantages of a federal proceeding. The firm advises buyers, sellers, lenders, and receivers across both cannabis and hemp transactions, structuring distressed deals so that regulatory approvals, license continuity, and creditor recoveries are all addressed before a transaction closes.

The firm provides Corporate Law services to cannabis and hemp operators and investors in:

Trusted Cannabis and Hemp Corporate Counsel

When well planned and executed, mergers and acquisitions can take an existing business to a level of increased capability, allow it to offer new goods or services, or assist in gaining market share. Since opening in 2018, The Law Office of Shay Aaron Gilmore has successfully closed millions of dollars in M&A transactional value for cannabis and hemp industry clients. To support these transactions, The Law Office of Shay Aaron Gilmore provides the following legal services:

What Business Entity Types Do You Recommend for New Cannabis Businesses?

From Shay’s interview for the Master’s series on ReelLawyers.com

View Transcript

Yeah, it really does depend on a number of considerations, including legal and regulatory compliance, tax implications, liability protection, access to capital, and management structure. Each of these factors can influence the client’s decision when forming a new cannabis business.

Representative matters

Represented the buyer of a licensed manufacturing subsidiary of a large, publicly traded cannabis company in a transaction exceeding USD 1.8 million, including negotiating satisfaction of historic tax liabilities shortly before the seller entered a court‑appointed receivership.
Took over an acquisition of a Northern California cannabis manufacturing and distribution business from prior counsel, re‑structuring the deal to fit California ownership‑transfer rules and securing regulatory approval after earlier efforts had stalled.
Acted for the seller of a multi‑million‑dollar cannabis cultivation farm in a coastal California county, structuring the sale and ownership transfer in a way that satisfied evolving state guidance on changes of control during a period of severe price compression for wholesale flower.
Led the corporate restructuring of several cannabis cultivation and retail businesses in different California counties, realigning ownership and governance in closely held companies, often in tandem with complex landlord, creditor, and social equity obligations.
Advised on entity governance and restructuring for social‑equity licensees and multi‑member retail ventures, including protecting majority owners who are also landlords while addressing aggressive minority stakeholders and potential litigation exposure.

Related cannabis and hemp business services include:

A complete list of Shay’s recent presentations, white papers, and legal articles is available on the Media page.

Shay regularly publishes Corporate Law updates and insights on his Cannabis and Hemp Law Blog.

Social Equity Structures, Entity Formation, and the Cannabis–Hemp Divide California’s cannabis social equity framework creates corporate‑structuring constraints that do not apply to industrial hemp. The Department of Cannabis Control offers equity fee relief — including license fee waivers and deferrals — to cannabis businesses that are at least 50% owned by qualifying equity applicants who meet criteria related to prior cannabis convictions, household income at or below 60% of area median income, or long‑term residence in communities disproportionately impacted by cannabis enforcement. Equity‑approved businesses may also qualify for the Franchise Tax Board’s cannabis equity tax credit of up to $10,000 per year through 2027, and eligible retailers could until recently retain 20% of excise tax collected under the CDTFA vendor compensation program. Dozens of local jurisdictions — including Los Angeles, Oakland, Sacramento, and San Francisco — layer on additional equity licensing programs with priority processing, technical assistance, and startup grants. Because equity status is tied directly to ownership percentages and individual qualifications, every corporate decision — formation, capitalization, investor admission, equity‑compensation grants, buyouts, and governance changes — must be evaluated against equity‑program thresholds. A funding round that dilutes the qualifying owner below 50%, or a management restructuring that changes who “directs or controls” the business under 4 CCR section 15003, can disqualify the company from equity benefits it has already been receiving. Industrial hemp operates under an entirely different framework. Hemp is regulated by the California Department of Food and Agriculture, not the DCC, and there is no parallel state social equity program for hemp cultivators or processors. Entity formation for hemp businesses is governed by standard California business law and the CDFA’s registration requirements for “key participants” — including sole proprietors, partners, and persons with executive managerial control — but without the equity‑ownership thresholds, ongoing disclosure obligations, or fee‑relief programs that shape cannabis corporate structures. That said, as the cannabis and hemp markets converge — particularly for companies that hold both DCC cannabis licenses and CDFA hemp registrations, or that are pivoting from one to the other — corporate counsel must understand both regulatory tracks to avoid inadvertently jeopardizing equity status, licensing, or registration through routine business transactions. The firm advises equity applicants, investors, and operators on structuring entities and capitalization tables so that equity ownership thresholds and key‑participant disclosures are maintained across both the cannabis and hemp regulatory frameworks.

Explore Our Corporate Law Services

Cannabis Business Entity Formation

How cannabis companies form consistent with corporate law and DCC regulations.

Cannabis Corporate Governance

How cannabis companies create governance systems for compliant operations.

Cannabis M&A Transactions

How cannabis companies structure mergers and deals under complex laws now.

Hemp Business Formation

How founders establish hemp businesses and comply with industry rules set.

Build the Corporate Foundation Before You Need It

Most corporate problems in cannabis are not surprises — they are predictable, and they are far cheaper to prevent than to litigate. A scoped consultation will give you a clear read on how your current structure performs under the conditions cannabis businesses actually face.